- Home
- QGEN vs PPC Comparison
QGEN vs PPC Comparison
Compare QGEN & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | PPC |
|---|---|---|
| Founded | 1986 | 1946 |
| Country | Netherlands | United States |
| Employees | N/A | 52100 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.7B |
| IPO Year | 1998 | 1997 |
Fundamental Metrics
Financial Performance| Metric | QGEN | PPC |
|---|---|---|
| Price | $42.13 | $37.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $51.30 | $44.33 |
| AVG Volume (30 Days) | ★ 1.7M | 859.7K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | 5.61% | ★ 21.74% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.54 |
| Revenue | N/A | ★ $18,497,553,000.00 |
| Revenue This Year | $8.23 | $2.39 |
| Revenue Next Year | $5.70 | $1.82 |
| P/E Ratio | $24.01 | ★ $8.51 |
| Revenue Growth | N/A | ★ 3.46 |
| 52 Week Low | $38.13 | $35.73 |
| 52 Week High | $57.82 | $56.73 |
Technical Indicators
Market Signals| Indicator | QGEN | PPC |
|---|---|---|
| Relative Strength Index (RSI) | 21.86 | 31.11 |
| Support Level | $41.11 | $36.63 |
| Resistance Level | $49.11 | $38.86 |
| Average True Range (ATR) | 0.88 | 1.01 |
| MACD | -0.72 | -0.49 |
| Stochastic Oscillator | 1.15 | 3.01 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS's offer undervalued Pilgrim's Pride.